Background: Cardiac amyloidosis (CA) involves the accumulation of amyloid fibrils in the extracellular cardiac spaces, increasing the extracellular volume (ECV) and correlating with poorer outcomes.

The ECV elevation tracked key cardiac imaging parameters such ... First, it highlights the technical progress in imaging for cardiac amyloid, both using CMR and bone tracers. Here the CMR was at 3T ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...

Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the ...

REPLY: Thank you for your eagle-eyed attention to detail and for bringing the inconsistency to our attention regarding the SPECT reconstruction display between 2 articles published in the June 2023 ...

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.

A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...